Home » Newsletters » BioWorld Science

BioWorld Science

March 11, 1997

View Archived Issues

Sankyo prepares antifungal agents

Gelatinase inhibitors prepared by Ono

Roussel Uclaf reports agents for BPH

Prostaglandin derivatives from Ono

MMP inhibitors described by Kureha

Merck KGaA's new ET antagonists

Na+/K+-exchange inhibitors from Merck KGaA

Novel LT biosynthesis inhibitor discovered by Abbott

Recombinant human hemoglobin produced by transgenic tobacco

Annual Report: Celltech

Annual Report: Ergo Science

Biogen and CV Therapeutics codevelop cardiovascular therapy

Novo Nordisk characterizes potential antipsychotic agent

Aradigm awarded NIH SBIR grant for respiratory disease therapy

AEterna enters into agreement to finance clinical studies with Neovastat

Successful animal study of PDIT for metastatic breast cancer

P-glycoprotein prevents absorption of saquinavir

Eurand develops taste-masked form of ketoprofen

PDT with Photofrin for early-stage esophageal and lung cancer

Painless local dermal anesthesia now available

Clinical testing of Visualine II tests completed

Cytogen seeks Canadian approval for Quadramet

Lark studies link between cell immortalization and tumor malignancy

Cel-Sci purchases complete rights to Multikine

Atorvastatin approved in Canada

LifeCell reports first sales of Alloderm products

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...